Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry appears to refer to a **topical combination product concept** containing **isopropyl alcohol**, **povidone-iodine**, **lidocaine hydrochloride**, and a **dexamethasone sodium salt**. Pharmacologically, the components would be expected to provide complementary local effects: isopropyl alcohol and povidone-iodine act as broad-spectrum antiseptics/disinfectants, lidocaine hydrochloride is a local anesthetic that blocks voltage-gated sodium channels to reduce pain, and dexamethasone sodium is a corticosteroid anti-inflammatory agent that modulates glucocorticoid receptor signaling. However, based on the provided context and public-source verification, the cited indication block clearly corresponds to **systemic dexamethasone injection labeling**, not to this exact four-ingredient combination, and I could not verify a concrete marketed or clinical-stage product matching this exact ingredient set. Accordingly, this record should be treated as a specific multi-ingredient drug name with **uncertain real-world product identity and unverified development history** rather than as a confirmed branded asset.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + povidone-iodine + lidocaine hydrochloride + dexamethasone sodium.